CJC-1295 Compounded Equivalent: Pricing, Access, and What to Know in 2026 At a glance Generic name / Modified GRF 1-29 (tetrasubstituted GRF 1-29) FDA approval status / No FDA-approved product exists Supply route / 503A and 503B compounding pharmacies only Typical monthly cost / $150 to $350 depending on dose and pharmacy Insurance coverage / Not covered by commercial or government plans Prescription required / Yes, from a licensed prescriber Common pairing / Ipamorelin (combined vial widely available) Typical dosing / 100 to 300 mcg subcutaneous injection, 1 to 3 times daily FDA regulatory note / FDA has placed CJC-1295 on the Category 2 bulk substance list for ongoing review Key safety signal / Injection-site reactions, flushing, transient hypotension reported in clinical studies Why CJC-1295 Exists Only as a Compounded Product No pharmaceutical manufacturer has submitted a New Drug Application for CJC-1295 to the FDA, so it has never received approval as a finished dosage form

Ideal for flights, road trips, or daily commutesno refrigeration stress required
Individual responses to these medications vary, and what works for one person may not be appropriate for another.
Based on advanced equipment and strict management, always pursue the "open, inclusion, innovation, sharing" business philosophy, creating a win-win cooperation platform
Most researchers prefer 2ml of bacteriostatic water for a 10mg vial
At the effect level, skin phototype and baseline melanin content also play a major role in how long Melanotan II seems to last